Navigation Links
Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Date:2/14/2008

1,700,240 783,311

------------------------------

Total current assets 66,182,142 71,700,228

------------------------------

EQUIPMENT AND LEASEHOLD IMPROVEMENTS:

Laboratory, office furniture and

equipment 2,863,244 2,462,647

Leasehold improvements 1,836,553 1,836,553

------------------------------

4,699,797 4,299,200

Less accumulated depreciation and

amortization (1,674,095) (1,437,080)

------------------------------

Total equipment and

leasehold improvements, net 3,025,702 2,862,120

OTHER ASSETS 487,793 1,282,051

------------------------------

TOTAL $69,695,637 $75,844,399

==============================

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:

Accounts payable $1,709,847 $3,281,600

Accrued expenses 3,007,366 5,513,407

Deferred rent 124,462 124,462

Current portion of capital lease

obligation 162,265 159,440

Deferred revenue 1,857,136 1,857,136

------------------------------

Total current liabilities 6,861,076 10,936,045

DEFERRED RENT
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. CEL-SCI Corporation Reports First Quarter Financial Results
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
11. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2008)... Abnormalities in audito...ldren with autism spectrum disorder by using magne...ented today at the annual meeting of the Radiologi...sing MEG, we can record the tiny magnetic fields a...mothy Roberts, Ph.D., vice chair of research in th...
(Date:11/28/2008)...v. 28 Eli Lilly and Comp... New Drug Application (sNDA) from,the U.S. Food a...xetine HCl),for the management of chronic pain. L...st half of 2009, adding data from a recently compl...n of the knee. , The decision does not affe...
(Date:11/26/2008)..., Nov. 26 Children whos...nificantly increased risk of developing mental ill... a Mayo Clinic study published this month in Pedia...my of Pediatrics. , , The retrospective stu...th strabismus (misaligned eyes) and compared them ...
(Date:11/26/2008)...o 406 Subjects , , FRANKLIN, Mass., Nov. 26...ulletin Board: PLCSF) announced today that it has ... Administration (FDA) for its U.S. pivotal trial t...ard System(TM) and associated therapy in the prev... , The FDA also approved PLC,s request to expa...
Breaking Medicine Technology:Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine 10264 1American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine 10264 2Regular marijuana use increases risk of hepatitis C related liver damage 10262 1Regular marijuana use increases risk of hepatitis C related liver damage 10262 2Regular marijuana use increases risk of hepatitis C related liver damage 10262 3CDC Report Highlights the Need for Safe Use and Safekeeping of Medicines 10260 1CDC Report Highlights the Need for Safe Use and Safekeeping of Medicines 10260 2ActivBiotics Completes Sale of Fixed Assets 3B Expands Due Diligence Initiative for the Sale of Intellectual Property Including Drug Product Candidat 2778 1
...ire/ -- MAP,Pharmaceuticals, Inc. today announced ...se Budesonide (UDB) pediatric asthma therapy,clini...fi Kirdar,Convention and Exhibition Center in Ista...ntitled, "Efficacy and safety,of a novel submicron...delivery in a 6 week study in 1-18 year old asthma...
... tumor lysate,triggers robust antigen-specific CTL..., June 22, 2007,/PRNewswire/ -- MaxCyte, Inc. and ...tion at the 13th Annual Meeting of the,Internation...ing,held June 24-27, 2007 in Sydney, Australia. , ...ture dendritic,cells with tumor lysate triggers ro...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
(Date:12/1/2008)... a cold December day in,Memphis, Tennessee and Fe...amilo Villegas and LPGA star Morgan Pressel have g...s that has brought three of the biggest names in,...e important than any game of,golf -- children bat...m.com/cgi-bin/prnh/20081201/CLM117 ) , Sin...
(Date:12/1/2008)...n the face of one of the most,severe economic dow...Board of,Directors has approved an investment of ...tter Health Retirement Plan. Employee pension plan... bonds, have been among the biggest,casualties of...tively,invested, the Sutter Health Retirement Pla...
(Date:12/1/2008)... Westaim Corporation today announced it has requis...ST Pharmaceuticals Corp. to consider a return of c...$15 million or US$0.80 per share. Westaim will con... of its 74.5 per cent stake in NUCRYST. Under the ... of Directors has 20 days to call a meeting of sha...
(Date:12/1/2008)...HICON, Inc., a Johnson & Johnson company, anno...of its Professional Wound Care business to One Equ...are not being disclosed. , , Under the term...ired the Professional Wound Care product portfolio...s PROMOGRAN Matrix Wound Dressing, TIELLE Hydropol...
Breaking Medicine News(10 mins):Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3
... disease through causing inflammation of the arter... may set the scene for heart disease. A new study ...C - reactive protein (CRP). Researchers at the Uni...th gum disease have higher than normal CRP levels....
...the back of the mouth is successful in relieving s...of women have a problem with snoring - and it gets... the soft palate - the area of tissue at the back ...e tonsils, and the base of the tongue. Surgery tha...
...mproves the paralysis experienced by stroke surviv...opamine in the body, and this may help brain cells... normally. It's used as a treatment in Parkinson's...a is also helpful in alleviating stroke-induced di...
...gh School of Medicine found that a treatment progr... weight is the first treatment to significantly im... Previous interventions for weight-concerned women...ing cessation was to help them prevent any weight ...
Other Medicine News:Health News:Stop smoking and reduce weight 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: